Literature DB >> 1729588

Adequacy and duration of antidepressant treatment in primary care.

W Katon1, M von Korff, E Lin, T Bush, J Ormel.   

Abstract

Among a sample of 119 distressed high-utilizers of primary care, 45% of patients evaluated by a psychiatrist as needing antidepressant treatment had been treated in the year before the examination. However, only 11% of the patients needing antidepressants had received adequate dosage and duration of pharmacotherapy. In the year following the intervention, study patients whose physicians were advised regarding treatment during a psychiatric consultation were more likely to receive antidepressant medications (52.7%) relative to a randomized control group (36.1%). However, the intervention did not significantly increase the provision of adequate antidepressant therapy (37.1% vs 27.9%). Among study patients using antidepressants, patient characteristics did not differentiate patients who received adequate dosage and duration of antidepressant medications from those who did not. Analysis of data on the duration of antidepressant therapy for all health maintenance organization enrollees initiating use of antidepressants showed that only 20% of patients who had been given prescriptions for first-generation antidepressants (amitriptyline, imipramine, or doxepin) filled four or more prescriptions in the following six months, compared to 34% of patients who had prescriptions for newer antidepressants (nortriptyline, desipramine, trazodone and fluoxetine). Experimental research evaluating whether these newer medications (with more favorable side effect profiles) improve adherence, and thereby patient outcome, is needed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729588     DOI: 10.1097/00005650-199201000-00007

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  92 in total

Review 1.  Pharmacological treatment of depression. Consulting with Dr Oscar.

Authors:  M J Berber
Journal:  Can Fam Physician       Date:  1999-11       Impact factor: 3.275

2.  Current issues in the economics of depression management.

Authors:  D Thompson; E Richardson
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

3.  Changing doctor prescribing behaviour.

Authors:  P S Gill; M Mäkelä; K M Vermeulen; N Freemantle; G Ryan; C Bond; T Thorsen; F M Haaijer-Ruskamp
Journal:  Pharm World Sci       Date:  1999-08

4.  Implementing an office system to improve primary care management of depression.

Authors:  Neil Korsen; Peter Scott; Allen J Dietrich; Thomas Oxman
Journal:  Psychiatr Q       Date:  2003

5.  A case report: implementing a nurse telecare program for treating depression in primary care.

Authors:  Joel F Meresman; Enid M Hunkeler; William A Hargreaves; Arlene J Kirsch; Patricia Robinson; Ann Green; Elvira Z Mann; Michael Getzell; Paul Feigenbaum
Journal:  Psychiatr Q       Date:  2003

Review 6.  The drive for quality care in US nursing homes in the era of the prospective payment system.

Authors:  Carmel M Hughes; Kate L Lapane
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  Reinvention of depression instruments by primary care clinicians.

Authors:  Seong-Yi Baik; Junius J Gonzales; Barbara J Bowers; Jean S Anthony; Bas Tidjani; Jeffrey L Susman
Journal:  Ann Fam Med       Date:  2010 May-Jun       Impact factor: 5.166

8.  Identification of patient attitudes and preferences regarding treatment of depression.

Authors:  L Cooper-Patrick; N R Powe; M W Jenckes; J J Gonzales; D M Levine; D E Ford
Journal:  J Gen Intern Med       Date:  1997-07       Impact factor: 5.128

Review 9.  Integrated primary mental health care: threat or opportunity in the new NHS?

Authors:  Helen Lester; Jon Glasby; André Tylee
Journal:  Br J Gen Pract       Date:  2004-04       Impact factor: 5.386

10.  The added costs of depression to medical care.

Authors:  K Franco; M Tamburino; N Campbell; J Zrull; C Evans; D Bronson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.